Clinical Trial Update: Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-

View source ↗

Summary

This clinical trial update indicates recruitment is ongoing to assess ablation of unresectable pancreatic cancer using the NanoKnife irreversible electroporatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• NanoKnife Irreversible Electroporation System

Snippet

Sponsor: Englewood Hospital and Medical Center | Conditions: Pancreatic Cancer Non-resectable | Status: RECRUITING